Therapeutics for Immune System Disorders
In 2010, the global market for drugs for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.
- An overview of the background science of the immune system, classifications of various molecules involved in immune responses, and types of immune responses
- Detailed discussion of various technology types used to contain undesirable immune responses and drugs in each category
- Global sales projections through 2015 for various technology types and immune disease categories
- Key players in the market and their market shares
- Analysis of the key challenges of the immune disease sector and its influence in the growth of the field
- A discussion of specific immune diseases and their therapies
- Technology trends and patent analysis
- In–depth analysis of leading companies and their successful strategies.
The past decade has seen an explosion in knowledge concerning the immune system, and this is leading to a wealth of new drugs and procedures that selectively target the causes of immune diseases. As a result, we forecast that the worldwide market for drugs that treat immune disease will grow from an estimated $31.5 billion in 2002 to $47.1 billion by 2007. These diseases are one of the largest market opportunities for pharmaceutical and biotechnology companies since they are common, chronic and historic treatments have been largely ineffective.
The study examines the current market for the treatment of immune disease and then projects the effects of new technologies upon this market. It makes detailed, unbiased market forecasts for the period of 2002 to 2007 and profiles the major companies involved in treating immune disease.